Evidence map›Paper›PMID 40464279›Full record

ArticleThe Cochrane database of systematic reviews2025

Immunomodulators and immunosuppressants for myasthenia gravis: a network meta-analysis.

Lucia B Varela, Nicolás Meza, Camila Micaela Escobar Liquitay, Samanta Díaz Menai, Juan Franco, Luis Garegnani

Abstract read
In one paragraph

Article in The Cochrane database of systematic reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Lucia B VarelaUniversidad Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Nicolás MezaInterdisciplinary Centre for Health Studies CIESAL, Universidad de Valparaíso, Viña del Mar, Chile.
Camila Micaela Escobar LiquitayUniversidad Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Samanta Díaz MenaiUniversidad Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
Juan FrancoCochrane Evidence Synthesis Unit Germany/UK Düsseldorf Subunit, Institute of General Practice, Centre for Health and Society, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Luis GaregnaniUniversidad Hospital Italiano de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesThis is a protocol for a Cochrane Review (intervention). The objectives are as follows: Primary To assess the comparative benefits and harms of immunomodulators and immunosuppressants for people with generalised myasthenia gravis through a network meta-analysis. Secondary To estimate the relative ranking of immunomodulators and immunosuppressants according to their effects.

Indexed as

Immunologic FactorsImmunomodulating AgentsImmunosuppressive AgentsMyasthenia GravisHumansNetwork Meta-Analysis as TopicRandomized Controlled Trials as TopicImmunologic FactorsImmunomodulating AgentsImmunosuppressive Agents

Identifiers

PMID40464279
PMCPMC12135144

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.